|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lianos GD, Rausei S, Ruspi L, Galli F,
Mangano A, Roukos DH, Dionigi G and Boni L: Laparoscopic
gastrectomy for gastric cancer: Current evidences. Int J Surg.
12:1369–1373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Boer M, van Dijck JA, Bult P, Borm GF
and Heijnen VC: Breast cancer prognosis and occult lymph node
metastases, isolated tumor cells, and micrometastases. J Natl
Cancer Inst. 102:410–425. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deng JY and Liang H: Clinical significance
of lymph node metastasis in gastric cancer. World J Gastroenterol.
20:3967–3975. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Velho S, Fernandes MS, Leite M, Figueiredo
C and Seruca R: Causes and consequences of microsatellite
instability in gastric carcinogenesis. World J Gastroenterol.
20:16433–16442. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paz H, Pathak N and Yang J: Invading one
step at a time: The role of invadopodia in tumor metastasis.
Oncogene. 33:4193–4202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 3:161–174. 2002. View
Article : Google Scholar
|
|
8
|
de la Peña S, Sampieri CL, Ochoa-Lara M,
León-Córdoba K and Remes-Troche JM: Expression of the matrix
metalloproteases 2, 14, 24 and 25 and tissue inhibitor 3 as
potential molecular markers in advanced human gastric cancer. Dis
Markers. 2014:2859062014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu PF, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dey S, Ghosh N, Saha D, Kesh K, Gupta A
and Swarnakar S: Matrix metalloproteinase-1 (MMP-1) promoter
polymorphisms are well linked with lower stomach tumor formation in
eastern Indian population. PLoS One. 9:e880402014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen WS, Xi HQ, Wei B and Chen L: The
prognostic role of matrix metalloproteinase 2 in gastric cancer: A
systematic review with meta-analysis. J Cancer Res Clin Oncol.
140:1003–1009. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mimori K, Fukagawa T, Kosaka Y, Ishikawa
K, Iwatsuki M, Yokobori T, Hirasaki S, Takatsuno Y, Sakashita H,
Ishii H, et al: A large-scale study of MT1-MMP as a marker for
isolated tumor cells in peripheral blood and bone marrow in gastric
cancer cases. Ann Surg Oncol. 15:2934–2942. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ninomiya T, Yoon S, Nagano H, Kumon Y, Seo
Y, Kasuga M, Yano Y, Nakaji M and Hayashi Y: Significance of serum
matrix metalloproteinases and their inhibitors on the
antifibrogenetic effect of interferon-alfa in chronic hepatitis C
patients. Intervirology. 44:227–231. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nuttall RK, Sampieri CL, Pennington CJ,
Gill SE, Schultz GA and Edwards DR: Expression analysis of the
entire MMP and TIMP gene families during mouse tissue development.
FEBS Lett. 563:129–134. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kemik O, Kemik AS, Sümer A, Dulger AC,
Adas M, Begenik H, Hasirci I, Yilmaz O, Purisa S, Kisli E, et al:
Levels of matrix metalloproteinase-1 and tissue inhibitors of
metalloproteinase-1 in gastric cancer. World J Gastroenterol.
17:2109–2112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Menghini R, Menini S, Amoruso R,
Fiorentino L, Casagrande V, Marzano V, Tornei F, Bertucci P,
Iacobini C, Serino M, et al: Tissue inhibitor of metalloproteinase
3 deficiency causes hepatic steatosis and adipose tissue
inflammation in mice. Gastroenterology. 136:663–672.e4. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoo EJ, Park SY, Cho NY, Kim N, Lee HS and
Kang GH: Helicobacter pylori-infection-associated CpG island
hypermethylation in the stomach and its possible association with
polycomb repressive marks. Virchows Arch. 452:514–524. 2008.
View Article : Google Scholar
|
|
18
|
Shin SH, Park SY, Ko JS, Kim N and Kang
GH: Aberrant CpG island hypermethylation in pediatric gastric
mucosa in association with Helicobacter pylori infection. Arch
Pathol Lab Med. 135:759–765. 2011.PubMed/NCBI
|
|
19
|
Yu JL, Lv P, Han J, Zhu X, Hong LL, Zhu
WY, Wang XB, Wu YC, Li P and Ling ZQ: Methylated TIMP-3 DNA in body
fluids is an independent prognostic factor for gastric cancer. Arch
Pathol Lab Med. 138:1466–1473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rocks N, Paulissen G, El Hour M, Quesada
F, Crahay C, Gueders M, Foidart JM, Noel A and Cataldo D: Emerging
roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie.
90:369–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim KE, Song H, Hahm C, Yoon SY, Park S,
Lee HR, Hur DY, Kim T, Kim CH, Bang SI, et al: Expression of ADAM33
is a novel regulatory mechanism in IL-18-secreted process in
gastric cancer. J Immunol. 182:3548–3555. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carl-McGrath S, Lendeckel U, Ebert M,
Roessner A and Röcken C: The disintegrin-metalloproteinases ADAM9,
ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol.
26:17–24. 2005.PubMed/NCBI
|
|
23
|
Folkman J: The role of angiogenesis in
tumor growth. Semin Cancer Biol. 3:65–71. 1992.PubMed/NCBI
|
|
24
|
Vermeulen PB, van Golen KL and Dirix LY:
Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli
in inflammatory breast cancer: A review of the current knowledge.
Cancer. 116 11 Suppl:S2748–S2754. 2010. View Article : Google Scholar
|
|
25
|
Raica M and Ribatti D: Targeting tumor
lymphangiogenesis: An update. Curr Med Chem. 17:698–708. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kostis G, Ioannis L, Helen K and Helen P:
The expression of vascular endothelial growth factor-C correlates
with lymphatic microvessel density and lymph node metastasis in
prostate carcinoma: An immunohistochemical study. Urol Ann.
6:224–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hoshida T, Isaka N, Hagendoorn J, di
Tomaso E, Chen YL, Pytowski B, Fukumura D, Padera TP and Jain RK:
Imaging steps of lymphatic metastasis reveals that vascular
endothelial growth factor-C increases metastasis by increasing
delivery of cancer cells to lymph nodes: Therapeutic implications.
Cancer Res. 66:8065–8075. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Harris NC, Davydova N, Roufail S,
Paquet-Fifield S, Paavonen K, Karnezis T, Zhang YF, Sato T,
Rothacker J, Nice EC, et al: The propeptides of VEGF-D determine
heparin binding, receptor heterodimerization, and effects on tumor
biology. J Biol Chem. 288:8176–8186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aoyagi K, Kouhuji K, Miyagi M, Kizaki J,
Isobe T, Hashimoto K and Shirouzu K: Molecular targeting therapy
using bevacizumab for peritoneal metastasis from gastric cancer.
World J Crit Care Med. 2:48–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shah MA, Jhawer M, Ilson DH, Lefkowitz RA,
Robinson E, Capanu M and Kelsen DP: Phase II study of modified
docetaxel, cisplatin, and fluorouracil with bevacizumab in patients
with metastatic gastroesophageal adenocarcinoma. J Clin Oncol.
29:868–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ohtsu A, Shah MA, Van Cutsem E, Rha SY,
Sawaki A, Park SR, Lim HY, Yamada Y, Wu J, Langer B, et al:
Bevacizumab in combination with chemotherapy as first-line therapy
in advanced gastric cancer: A randomized, double-blind,
placebo-controlled phase III study. J Clin Oncol. 29:3968–3976.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shah MA, Ramanathan RK, Ilson DH, Levnor
A, D'Adamo D, O'Reilly E, Tse A, Trocola R, Schwartz L, Capanu M,
et al: Multicenter phase II study of irinotecan, cisplatin and
bevacizumab in patients with metastatic gastric or gastroesophageal
junction adenocarcinoma. J Clin Oncol. 24:5201–5206. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gou HF, Chen XC, Zhu J, Jiang M, Yang Y,
Cao D and Hou M: Expressions of COX-2 and VEGF-C in gastric cancer:
Correlations with lymphangiogenesis and prognostic implications. J
Exp Clin Cancer Res. 30:142011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Botting SK, Fouad H, Elwell K, Rampy BA,
Salama SA, Freeman DH and Diaz-Arrastia CR: Prognostic significance
of peritumoral lymphatic vessel density and vascular endothelial
growth factor receptor 3 in invasive squamous cell cervical cancer.
Transl Oncol. 3:170–175. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao R, Björndahl MA, Religa P, Clasper S,
Garvin S, Galter D, Meister B, Ikomi F, Tritsaris K, Dissing S, et
al: PDGF-BB induces intratumoral lymphangiogenesis and promotes
lymphatic metastasis. Cancer Cell. 6:333–345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Björndahl M, Cao R, Nissen LJ, Clasper S,
Johnson LA, Xue Y, Zhou Z, Jackson D, Hansen A and Cao YH:
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in
vivo. Proc Natl Acad Sci USA. 102:pp. 15593–15598. 2005; View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Platonova N, Miquel G, Regenfuss B, Taouji
S, Cursiefen S, Chevet E and Bikfalvi A: Evidence for the
interaction of fibroblast growth factor-2 with the lymphatic
endothelial cell marker LYVE-1. Blood. 121:1229–1237. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schulz MM, Reisen F, Zgraggen S, Fischer
S, Yuen D, Kang GJ, Chen L, Schneider G and Detmar M:
Phenotype-based high-content chemical library screening identifies
statins as inhibitors of in vivo lymphangiogenesis. Proc Natl Acad
Sci USA. 109:pp. E2665–E2674. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cao R, Björndahl MA, Gallego MI, Chen S,
Religa P, Hansen AJ and Cao Y: Hepatocyte growth factor is a
lymphangiogenic factor with an indirect mechanism of action. Blood.
107:3531–3536. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Holopainen T, Saharinen P, D'Amico G,
Lampinen A, Eklund L, Sormunen R, Anisimov A, Zarkada G, Lohela M,
Heloterä H, et al: Effects of angiopoietin-2-blocking antibody on
endothelial cell-cell junctions and lung metastasis. J Natl Cancer
Inst. 104:461–475. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sumida H, Yanagida K, Kita Y, Abe J,
Matsushima K, Nakamura M, Ishii S, Sato S and Shimizu T: Interplay
between CXCR2 and BLT1 facilitates neutrophil infiltration and
resultant keratinocyte activation in a murine model of
imiquimod-induced psoriasis. J Immunol. 192:4361–4369. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chiba F, Soda K, Yamada S, Tokutake Y,
Chohnan S and Konishi F: The importance of tissue environment
surrounding the tumor on the development of cancer cachexia. Int J
Oncol. 44:177–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cheng WL, Wang CS, Huang YH, Tsai MM,
Liang Y and Lin KH: Overexpression of CXCL1 and its receptor CXCR2
promote tumor invasion in gastric cancer. Ann Oncol. 22:2267–2276.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xiang Z, Zhou ZJ, Xia GK, Zhang XH, Wei
ZW, Zhu JT, Yu J, Chen W, He Y, Schwarz RE, et al: A positive
crosstalk between CXCR4 and CXCR2 promotes gastric cancer
metastasis. Oncogene. 34:5122–5133. 2015.
|
|
45
|
Itakura M, Tokuda A, Kimura H, Nagai S,
Yoneyama H, Onai N, Ishikawa S, Kuriyama T and Matsushima K:
Blockade of secondary lymphoid tissue chemokine
exacerbatesPropionibacterium acnes-induced acute lung inflammation.
J Immunol. 3:2071–2079. 2001. View Article : Google Scholar
|
|
46
|
Du P, Liu Y, Ren H, Zhao J, Zhang X, Patel
R, Hu C, Gan J and Huang G: Expression of chemokine receptor CCR7
is a negative prognostic factor for patients with gastric cancer: A
meta-analysis. Gastric Cancer. 20:235–245. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ma H, Gao L, Li S, Qin J, Chen L, Liu X,
Xu P, Wang F, Xiao H, Zhou S, et al: CCR7 enhances TGF-β1-induced
epithelial-mesenchymal transition and is associated with lymph node
metastasis and poor overall survival in gastric cancer. Oncotarget.
6:24348–24360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang J, Zhou Y and Yang Y: CCR7 pathway
induces epithelial-mesenchymal transition through up-regulation of
Snail signaling in gastric cancer. Med Oncol. 32:4672015.PubMed/NCBI
|
|
49
|
Vela M, Aris M, Llorente M, Garcia-Sanz JA
and Kremer L: Chemokine receptor-specific antibodies in cancer
immunotherapy: Achievements and challenges. Front Immunol.
6:122015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Le Bras GF, Taubenslag KJ and Andl CD: The
regulation of cell-cell adhesion during epithelial-mesenchymal
transition, motility and tumor progression. Cell Adh Migr.
6:365–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhong X and Rescorla FJ: Cell surface
adhesion molecules and adhesion-initiated signaling: Understanding
of anoikis resistance mechanisms and therapeutic opportunities.
Cell Signal. 24:393–401. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kim YJ, Borsig L, Han HL, Varki NM and
Varki A: Distinct selectin ligands on colon carcinoma mucins can
mediate pathological interactions among platelets, leukocytes and
endothelium. Am J Pathol. 155:461–472. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ke JJ, Shao QS and Ling ZQ: Expression of
E-selectin, integrin beta1 and immunoglobulin superfamily member in
human gastric carcinoma cells and its clinicopathologic
significance. World J Gastroenterol. 12:3609–3611. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu Y, Zhao J, Zhang PY, Zhang Y, Sun SY,
Yu SY and Xi QS: MicroRNA-10b targets E-cadherin and modulates
breast cancer metastasis. Med Sci Monit. 18:BR299–BR308. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen Y, Xiang H, Zhang Y, Wang J and Yu G:
Loss of PCDH9 is associated with the differentiation of tumor cells
and metastasis and predicts poor survival in gastric cancer. Clin
Exp Metastasis. 32:417–428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bevilacqua MP and Nelson RM: Selectins. J
Clin Invest. 91:379–387. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Benekli M, Güllü IH, Tekuzman G, Savaş MC,
Hayran M, Hasçelik G and Firat D: Circulating intercellular
adhesion molecule-1 and E-selectin levels in gastric cancer. Br J
Cancer. 78:267–271. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Borsig L, Wong R, Hynes RO, Varki NM and
Varki A: Synergistic effects of L- and P-selectin in facilitating
tumor metastasis can involve non-mucin ligands and implicate
leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA.
99:pp. 2193–2198. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Makrilia N, Kollias A, Manolopoulos L and
Syrigos K: Cell adhesion molecules: Role and clinical significance
in cancer. Cancer Invest. 27:1023–1037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yashiro M, Sunami T and Hirakawa K: CD54
expression is predictive for lymphatic spread in human gastric
carcinoma. Dig Dis Sci. 50:2224–2230. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Maruo Y, Gochi A, Kaihara A, Shimamura H,
Yamada T, Tanaka N and Orita K: ICAM-1 expression and the soluble
ICAM-1 level for evaluating the metastatic potential of gastric
cancer. Int J Cancer. 100:486–490. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Jung WC, Jang YJ, Kim JH, Park SS, Park
SH, Kim SJ, Mok YJ and Kim CS: Expression of intercellular adhesion
molecule-1 and E-Selectin in gastric cancer and their clinical
significance. J Gastric Cancer. 12:140–148. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hsu NY, Chow KC, Chen WJ, Lin CC, Chou FF
and Chen CL: Expression of nm23 in the primary tumor and the
metastatic regional lymph nodes of patients with gastric cardiac
cancer. Clin Cancer Res. 5:1752–1757. 1999.PubMed/NCBI
|
|
64
|
Kim KM, Lee A, Chae HS and Shim SI:
Expression of p53 and NDP-K/nm23 in gastric carcinomas-association
with metastasis and clinicopathologic parameters. J Korean Med Sci.
10:406–413. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yu G, Wang J, Chen Y, Wang X, Pan J, Li Q
and Xie K: Tissue microarray analysis reveals strong clinical
evidence for a close association between loss of annexin A1
expression and nodal metastasis in gastric cancer. Clin Exp
Metastasis. 25:695–702. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Li Y, Wang L, Kang A, Fan L, Zhao Q, Tan
B, Hao Y and Liu Q: Screening and identification of proteins
related to gastric cancer metastasis with comparative proteomics.
Nan Fang Yi Ke Da Xue Xue Bao. 35:360–364. 2015.(In Chinese).
PubMed/NCBI
|
|
67
|
Li Y, Tan BB, Zhao Q, Fan LQ, Liu Y and
Wang D: Regulatory mechanism of ZNF139 in multi-drug resistance of
gastric cancer cells. Mol Biol Rep. 41:3603–3610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Li Y, Tan BB, Zhao Q, Fan LQ, Wang D and
Liu Y: ZNF139 promotes tumor metastasis by increasing migration and
invasion in human gastric cancer cells. Neoplasma. 61:291–298.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ikeda Y, Mori M, Kajiyama K, Haraguchi Y,
Sasaki O and Sugimachi K: Immunohistochemical expression of sialyl
Tn, sialyl Lewis a, sialyl Lewis a-b- and sialyl Lewis × in primary
tumor and metastatic lymph nodes in human gastric cancer. J Surg
Oncol. 62:171–176. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Pahujaa M, Anikin M and Goldberg GS:
Phosphorylation of connexin43 induced by Src: Regulation of gap
junctional communication between transformed cells. Exp Cell Res.
313:4083–4090. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
El-Sabban ME and Pauli BU:
Adhesion-mediated gap junctional communication between
lung-metastatatic cancer cells and endothelium. Invasion
Metastasis. 14:164–176. 1994.PubMed/NCBI
|
|
72
|
Tang B, Peng ZH, Yu PW, Yu G and Qian F:
Expression and significance of Cx43 and E-cadherin in gastric
cancer and metastatic lymph nodes. Med Oncol. 28:502–508. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Paliouras GN, Naujokas MA and Park M:
Pak4, a novel Gab1 binding partner, modulates cell migration and
invasion by the Met receptor. Mol Cell Biol. 29:3018–3032. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Gherardi E, Birchmeier W, Birchmeier C and
Woude GV: Targeting MET in cancer: Rationale and progress. Nat Rev
Cancer. 12:89–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ma J, Ma J, Meng Q, Zhao ZS and Xu WJ:
Prognostic value and clinical pathology of MACC-1 and c-MET
expression in gastric carcinoma. Pathol Oncol Res. 19:821–832.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Comoglio PM, Giordano S and Trusolino L:
Drug development of MET inhibitors: Targeting oncogene addiction
and expedience. Nat Rev Drug Discov. 7:504–516. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Chan AM, Rubin JS, Bottaro DP, Hirschfield
DW, Chedid M and Aaronson SA: Identification of a competitive HGF
antagonist encoded by an alternative transcript. Science.
254:1382–1385. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Mihailidou C, Karamouzis MV, Schizas D and
Papavassiliou AG: Co-targeting c-Met and DNA double-strand breaks
(DSBs): Therapeutic strategies in BRCA-mutated gastric carcinomas.
Biochimie. 142:135–143. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Tian M, Yu L, Zhang Y and Gao X:
Correlations between SUVmax and expression of GLUT1 and growth
factors inducing lymphangiogenesis. Acad Radiol. 19:420–426. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Meng F, Li H, Shi H, Yang Q, Zhang F, Yang
Y, Kang L, Zhen T, Dai S, Dong Y and Han A: MACC1 down-regulation
inhibits proliferation and tumourigenicity of nasopharyngeal
carcinoma cells through Akt/β-catenin signaling pathway. PLoS One.
8:e608212013. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Mak H, Naba A, Varma S, Schick C, Day A,
SenGupta SK, Arpin M and Elliott BE: Ezrin phosphorylation on
tyrosine 477 regulates invasion and metastasis of breast cancer
cells. BMC Cancer. 12:822012. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wu B, Li J, Huang D, Wang W, Chen Y, Liao
Y, Tang X, Xie H and Tang F: Baicalein mediates inhibition of
migration and invasiveness of skin carcinoma through Ezrin in A431
cells. BMC Cancer. 11:5272011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li L, Wang YY, Zhao ZS and Ma J: Ezrin is
associated with gastric cancer progression and prognosis. Pathol
Oncol Res. 17:909–915. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Jin J, Jin T, Quan M, Piao Y and Lin Z:
Ezrin overexpression predicts the poor prognosis of gastric
adenocarcinoma. Diagn Pathol. 7:1352012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Dong CX, Fu JF, Ye XY, Li XF, Zhong X and
Yuan Y: Surgical resection of advanced gastric cancer following
trastuzumab/oxaliplatin/capecitabine combination therapy. World J
Gastroenterol. 20:12355–12358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kim K, Chun KH, Suh PG and Kim IH:
Alterations in cell proliferation related gene expressions in
gastric cancer. Crit Rev Eukaryot Gene Expr. 21:237–254. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Birchmeier C, Birchmeier W, Gherardi E and
Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol
Cell Biol. 4:915–925. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Okines AF, Reynolds AR and Cunningham D:
Targeting angiogenesis in esophagogastric adenocarcinoma.
Oncologist. 16:844–858. 2011. View Article : Google Scholar : PubMed/NCBI
|
